Home
>
National Drug Code (NDC)
>
Cefuroxime Sodium
Cefuroxime Sodium - 25021-118-10 - (Cefuroxime Sodium)
Drug Information of Cefuroxime Sodium
| Product NDC: | 25021-118 |
| Proprietary Name: | Cefuroxime Sodium |
| Non Proprietary Name: | Cefuroxime Sodium |
| Active Ingredient(s): | 750 mg/1 & nbsp; Cefuroxime Sodium |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cefuroxime Sodium
| Product NDC: | 25021-118 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065048 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080501 |
Package Information of Cefuroxime Sodium
| Package NDC: | 25021-118-10 |
| Package Description: | 25 VIAL in 1 CARTON (25021-118-10) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
NDC Information of Cefuroxime Sodium
| NDC Code | 25021-118-10 |
| Proprietary Name | Cefuroxime Sodium |
| Package Description | 25 VIAL in 1 CARTON (25021-118-10) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| Product NDC | 25021-118 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cefuroxime Sodium |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20080501 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | CEFUROXIME SODIUM |
| Strength Number | 750 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |
